Evidence map›Paper›PMID 38740467›Full record

ArticleJournal of the American Board of Family Medicine : JABFM

The Impact of the COVID-19 Pandemic on Patient Disparities in Long-Term Opioid Therapy.

Sebastian T Tong, Zihan Zheng, Maria G Prado, Imara I West, Joseph W LeMaster, Mary A Hatch, Lili S Szabo, Tracy M Anastas, Kris Pui Kwan Ma, Kari A Stephens

Abstract read
In one paragraph

Article in Journal of the American Board of Family Medicine : JABFM. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sebastian T TongFrom the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL).
Zihan ZhengFrom the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL).
Maria G PradoFrom the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL).
Imara I WestFrom the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL).
Joseph W LeMasterFrom the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL).
Mary A HatchFrom the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL).
Lili S SzaboFrom the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL).
Tracy M AnastasFrom the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL).
Kris Pui Kwan MaFrom the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL).
Kari A StephensFrom the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL).

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Clinical Trials Network: Pacific Northwest Node (CTN-0082, -0131, -0139 and dissemination library)UG1DA013714 · NIDA · UNIVERSITY OF WASHINGTON · PI Mary Akiko Hatch, John M. Roll · 2015 to 2026
$19.8M
Psychiatry Primary Care NRSA T-32 AwardT32MH020021 · NIMH · UNIVERSITY OF WASHINGTON · PI JOHN C. FORTNEY, JURGEN UNUTZER · 1998 to 2026
$5.6M
NCATS NIH HHS UL1 TR002319NIDA NIH HHS UG1 DA013714NIMH NIH HHS T32 MH020021
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic disrupted how primary care patients with chronic pain received care. Our study sought to understand how long-term opioid therapy (LtOT) for chronic pain changed over the course of the pandemic overall and for different demographic subgroups.

methodsWe used data from electronic health records of 64 primary care clinics across Washington state and Idaho to identify patients who had a chronic pain diagnosis and were receiving long-term opioid therapy. We defined 10-month periods in 2019 to 2021 as prepandemic, early pandemic and late pandemic and used generalized estimating equations analysis to compare across these time periods and demographic characteristics.

resultsWe found a proportional decrease in LtOT for chronic pain in the early months of the pandemic (OR = 0.94, DISCUSSION: The use of LtOT for chronic pain in primary care has increased from before to after the COVID-19 pandemic with racial/ethnic and geographic disparities. Future research is needed to understand these disparities in LtOT and their effect on patient outcomes.

Indexed as

Analgesics, OpioidChronic PainCOVID-19Healthcare DisparitiesPrimary Health CareAdultAgedFemaleHumansIdahoMaleMiddle AgedPandemicsSARS-CoV-2WashingtonAnalgesics, OpioidChronic PainCOVID-19Healthcare DisparitiesIdahoOpioidsPandemicsPrimary Health CareSubstance Use DisordersWashington

Identifiers

PMID38740467
PMCPMC12874994

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.